Myriad Genetics director granted 59,701 RSUs
Phanstiel S. Louise reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Phanstiel S. Louise reported acquisition or exercise transactions in this Form 4 filing.
Myriad Genetics Inc. director S. Louise Phanstiel received an equity award of 59,701 restricted stock units (RSUs). The award was granted under the company’s 2026 Employee, Director and Consultant Equity Incentive Plan at no cash cost to the director.
Each RSU represents a contingent right to receive one share of Myriad Genetics common stock and will vest upon the earlier of the first anniversary of the grant date or the next annual meeting of stockholders following the grant. After this grant, Phanstiel directly holds 341,652 shares of common stock, reflecting her updated ownership position including the new award.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 59,701 | $0.00 | $0.00 |
Footnotes (1)
- F1. Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.
Key Figures
Key Terms
restricted stock units financial
contingent right financial
Equity Incentive Plan financial
vests financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Myriad Genetics (MYGN) report for S. Louise Phanstiel?
What are the vesting terms of the 59,701 restricted stock units granted by Myriad Genetics (MYGN)?
Under which plan were the Myriad Genetics (MYGN) restricted stock units granted to S. Louise Phanstiel?
AI-generated analysis. How Rhea-AI works. Not financial advice.